Cargando…
A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate
Ovarian cancer (OC) is the leading cause of gynecological cancer deaths. Extraordinary histologic and genetic heterogeneity presents as great hurdle to OC's diagnosis and treatment. MRPS12 (Mitochondrial Ribosomal Protein S12), encoding a 28S subunit protein, controls the decoding fidelity and...
Autores principales: | Qiu, Xiaofeng, Guo, Dongxia, Du, Juan, Bai, Yuhuan, Wang, Fengying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909224/ https://www.ncbi.nlm.nih.gov/pubmed/33663122 http://dx.doi.org/10.1097/MD.0000000000024898 |
Ejemplares similares
-
Circulating microRNAs as candidate biomarkers for the ovarian response during in vitro fertilization
por: Zhao, Hongjuan, et al.
Publicado: (2021) -
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
por: Hada, Taira, et al.
Publicado: (2021) -
Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer
por: Zhang, Xue-ying, et al.
Publicado: (2021) -
Prognostic significance of lymphocyte monocyte ratio in patients with ovarian cancer
por: Cai, Linrui, et al.
Publicado: (2020) -
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes
por: Nie, Xiazi, et al.
Publicado: (2021)